330 related articles for article (PubMed ID: 3545455)
21. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.
Mobbs BG; Johnson IE
J Steroid Biochem; 1987 Dec; 28(6):653-62. PubMed ID: 3320574
[TBL] [Abstract][Full Text] [Related]
22. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
[TBL] [Abstract][Full Text] [Related]
23. Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor.
Blankenstein MA; Berns PM; Blaauw G; Mulder E; Thijssen JH
Cancer Res; 1986 Aug; 46(8 Suppl):4268s-4270s. PubMed ID: 3731090
[TBL] [Abstract][Full Text] [Related]
24. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors.
Cappelletti V; Brivio M; Miodini P; Granata G; Coradini D; Di Fronzo G
Tumour Biol; 1988; 9(4):200-11. PubMed ID: 3420376
[TBL] [Abstract][Full Text] [Related]
26. Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.
Kastelan M; Rudolf M; Hrsak M; Stojkovic R; Gamulin S
Biomed Pharmacother; 1985; 39(8):442-4. PubMed ID: 3834952
[TBL] [Abstract][Full Text] [Related]
27. Improved measurement of androgen receptors in human breast cancer.
Lea OA; Kvinnsland S; Thorsen T
Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
[TBL] [Abstract][Full Text] [Related]
28. [Biological and clinical analysis of breast cancer in relation to hormone receptors].
Akagi M; Iwaki J; Kimura M; Kihara S; Maeno M; Nishimura R; Araki K; Egami H; Yamashita J; Shigaki N; Fujino N
Gan No Rinsho; 1983 May; 29(6):632-6. PubMed ID: 6876432
[TBL] [Abstract][Full Text] [Related]
29. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
Pewnim T; Adams JB; Ho KP
Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
31. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
Ben-David M; Wittliff JL; Fekete M; Kadar T; Biran S; Schally AV
Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209
[TBL] [Abstract][Full Text] [Related]
32. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
33. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
34. Histochemical studies with an estrogen receptor-related protein in human breast tumors.
Cano A; Coffer AI; Adatia R; Millis RR; Rubens RD; King RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6475-80. PubMed ID: 3536082
[TBL] [Abstract][Full Text] [Related]
35. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
37. Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice.
Kubota T; Josui K; Fukutomi T; Kitajima M
Anticancer Res; 1995; 15(4):1275-8. PubMed ID: 7654008
[TBL] [Abstract][Full Text] [Related]
38. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
40. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium.
Neumannova M; Kauppila A; Vihko R
Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
